Oct 31, 2014

Clinical use of continuous glucose monitoring system in gestational diabetes mellitus and type 2 diabetes complicated with pregnancy

Zhonghua fu chan ke za zhi
Yilin Song, Huixia Yang

Abstract

To compare the clinical use of continuous glucose monitoring system (CGMS) and self-monitoring blood glucose (SMBG) when monitoring blood glucose level of patients with gestational diabetes mellitus (GDM) or type 2 diabetes mellitus (DM) complicated with pregnancy. A total of 99 patients with GDM (n = 70) and type 2 DM complicated with pregnancy (n = 29) that whether hospitalized or in clinical of Peking University First Hospital were recruited from Aug 2012 to Apr 2013. The CGMS was used to monitor their blood glucose level during the 72-hour time period, while the SMBG was also taken seven times daily. The correlation between these blood glucose levels and their glycosylated hemoglobin (HbA1c) levels were analyzed by comparing the average value, the maximum and the minimum value of blood glucose, and the appeared time of these extremum values in these two monitoring methods, and the amount of insulin usage was recorded as well. (1) The maximum, minimum and the average blood glucose value in the GDM group were (8.7 ± 1.2), (4.5 ± 0.6)and (6.3 ± 0.6)mmol/L of SMBG vs. (10.1 ± 1.7), (3.1 ± 0.7), (6.0 ± 0.6) mmol/L of CGMS. These values in DM group were(10.1 ± 2.2), (4.5 ± 1.0), (6.9 ± 1.1)mmol/L of SMBG vs.(12.2 ± 2.6), (2.8 ± 0...Continue Reading

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Glycated Hemoglobin TEST
Diabetes Mellitus, Non-Insulin-Dependent
Hemoglobin, Glycosylated
Pregnancy in Diabetics
Impaired Glucose Tolerance
Gestational Diabetes
Pregnancy Complications
Blood Glucose Measurement
Glucohemoglobin Measurement
Blood Glucose Self-Monitoring

About this Paper

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Katarzyna CyprykAndrzej Lewiński
Medicinski Glasnik : Official Publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina
Davut BaltaciHandan Ankarali
© 2020 Meta ULC. All rights reserved